Research and Clinical Trials

Research and Clinical Trials

Learning About Advances for Prevention, Diagnosis and Treatment

 
The BTTC has experienced unparalleled advancements in the research of alternative treatments of malignant brain tumors. Subsequently research studies, also known as clinical trials, are being conducted to learn about promising advances for cancer prevention, diagnosis and safe and effective treatments.
 
Since its inception, the BTTC has completed accrual on a number of clinical trials. Once data from the trials is compiled and results published, we will gleam insightful conclusions in our fight against brain cancer. Stay Tuned!
 
In addition, we have several exciting new research concepts being presented by our BTTC members. We will share them with you as we get ready and open for accrual.

Brain Tumor Research

Malignant glioma brain tumor have the greatest incidence rate in adults, while the survival rate remains poor. Pre-clinical data suggests alternative therapy strategies, including a multi-targeted approach, might be more effective in controlling the tumor and subsequently improving survival.
Learn more about BTTC Research

Clinical Trial Basics

Within the world of cancer research, four types of clinical trials exist — prevention, diagnosis, screening and quality of life.
Learn more about the Clinical Trial Basics

BTTC Clinical Trials

The current treatment of malignant gliomas, the most common brain tumor in adults, remains challenging and less effective than desired. Several trials are in various planning stages, but three BTTC clinical trials are under way. These trials hope to deliver results that provide a more effective treatment therapy in controlling the tumor and, ultimately, increasing survival.
Learn more about BTTC Clinical Trials